Nigeria Receives 100,000 Doses Of COVID-19 Vaccines From India
Covishield is Serum Institute of India’s version of AZD1222, a vaccine developed by AstraZeneca in collaboration with University of Oxford.
Mustapha, who is also Secretary to the Government of the Federation, confirmed this on Tuesday at the national briefing in Abuja.
As you are aware, Nigeria received 3.94 million doses of the COVID-19 Oxford/AstraZeneca vaccine on March 2, 2021. These vaccines represented the first tranche of about 16 million doses allocated to Nigeria through the COVAX facility, aimed at vaccinating an initial 20 per cent of the population.
More vaccines are also expected from the African Union’s Vaccine Acquisition Task Team (AVATT). We shall also be receiving about 100,000 doses of Covishield vaccines donated by the Government of India to Nigeria. This will further boost the number of Nigerians to be vaccinated by about 50,000.
The PTF through the Federal Ministry of Health (FMoH) and the National Primary Health Center Development Agency (NPHCDA) prioritised the initial consignment of vaccines to cover frontline medical personnel, strategic leadership, and those above the age of 50 years across the nation. Majority of sub-national entities have already received their allocation and administration is progressing.
Giving an update about vaccination process, Mustapha said;
As at April 5, 2021, 963,802 persons in Nigeria had received the first dose of the COVID-19 vaccine. The overarching objective is to vaccinate 70 per cent of Nigeria’s population between 2021 and 2022.